Alpha-halocarboxylic acids and derivatives

Organic compounds that contain a carboxyl group bonded to a halogen group in the alpha position; halogen groups consist of one or more halogen atoms (F, Cl, B, I, At). Includes compounds that are derived from alpha-halocarboxylic acids.

Search Within Results

496 – 510 of 577 results

496

eMolecules 5437-45-6 | Benzyl 2-bromoacetate | Ambeed | MFCD00000190 | 229.073 | C9H9BrO2 | 98.000 | BrCC(=O)OCc1ccccc1 | 25g | 525116708

Benzyl 2-bromoacetate | Ambeed | 5437-45-6 | MFCD00000190 | 229.073 | C9H9BrO2 | 98.000 | BrCC(=O)OCc1ccccc1 | 25g | 525116708

Pricing & Availability

497

Bioss GRIP1 Associated Protein 1 GRA

GRIP1 Associated Protein 1 GRASP1 Antibody

Pricing & Availability

498

eMolecules 5292-43-3 | tert-Butyl bromoacetate | Key Organics/BIONET | MFCD00000188 | 195.056 | C6H11BrO2 | 95.000 | CC(C)(C)OC(=O)CBr | 5mg | 564178900

tert-Butyl bromoacetate | Key Organics/BIONET | 5292-43-3 | MFCD00000188 | 195.056 | C6H11BrO2 | 95.000 | CC(C)(C)OC(=O)CBr | 5mg | 564178900

Pricing & Availability

499

eMolecules 5437-45-6 | Benzyl 2-bromoacetate | AA Blocks LLC | MFCD00000190 | 229.073 | C9H9BrO2 | 0.000 | BrCC(=O)OCc1ccccc1 | 25g | 437039660

Benzyl 2-bromoacetate | AA Blocks LLC | 5437-45-6 | MFCD00000190 | 229.073 | C9H9BrO2 | 0.000 | BrCC(=O)OCc1ccccc1 | 25g | 437039660

Pricing & Availability

500

eMolecules 5437-45-6 | Benzyl 2-bromoacetate | AA Blocks LLC | MFCD00000190 | 229.073 | C9H9BrO2 | 0.000 | BrCC(=O)OCc1ccccc1 | 100g | 460592293

Benzyl 2-bromoacetate | AA Blocks LLC | 5437-45-6 | MFCD00000190 | 229.073 | C9H9BrO2 | 0.000 | BrCC(=O)OCc1ccccc1 | 100g | 460592293

Pricing & Availability

501

eMolecules 5292-43-3 | tert-Butyl bromoacetate | Key Organics/BIONET | MFCD00000188 | 195.056 | C6H11BrO2 | 95.000 | CC(C)(C)OC(=O)CBr | 1mg | 564178899

tert-Butyl bromoacetate | Key Organics/BIONET | 5292-43-3 | MFCD00000188 | 195.056 | C6H11BrO2 | 95.000 | CC(C)(C)OC(=O)CBr | 1mg | 564178899

Pricing & Availability

502

eMolecules 5292-43-3 | tert-Butyl bromoacetate | Key Organics/BIONET | MFCD00000188 | 195.056 | C6H11BrO2 | 95.000 | CC(C)(C)OC(=O)CBr | 10mg | 564178901

tert-Butyl bromoacetate | Key Organics/BIONET | 5292-43-3 | MFCD00000188 | 195.056 | C6H11BrO2 | 95.000 | CC(C)(C)OC(=O)CBr | 10mg | 564178901

Pricing & Availability

503

eMolecules 5292-43-3 | tert-Butyl bromoacetate | Key Organics/BIONET | MFCD00000188 | 195.056 | C6H11BrO2 | 95.000 | CC(C)(C)OC(=O)CBr | 50mg | 564178902

tert-Butyl bromoacetate | Key Organics/BIONET | 5292-43-3 | MFCD00000188 | 195.056 | C6H11BrO2 | 95.000 | CC(C)(C)OC(=O)CBr | 50mg | 564178902

Pricing & Availability

504

Medchemexpress LLC GRA Ex-25 | 307983-31-9 | 99.1% | C29H36F3N3O5 | 5 MG

GRA Ex-25 is an inhibitor of glucagon receptor, with IC50 of 56 and 55 nM for rat and human glucagon receptors, respectively. It binds a human glucagon receptor (h-GlucRbind) with a Ki of 63 nM and shows moderate glucagon-induced adenylate cyclase inhibition (h-GlucRcyclase) with a Ki of 254 nM. It significantly reduces blood glucose caused by exogenous administration of glucagon in a rat model by inhibiting the rise in blood glucose levels elicited by exogenously administered glucagon, most likely due to direct inhibition of glucagon-stimulated hepatic glucose output. Intended for research use only.

Inhibits glucagon receptor.
IC50 of 56 nM for rat glucagon receptors.
IC50 of 55 nM for human glucagon receptors.
Binds human glucagon receptor with a Ki of 63 nM.
Shows moderate glucagon-induced adenylate cyclase inhibition with a Ki of 254 nM.
Significantly reduces blood glucose in a rat model.